# Role of Beta-Endorphin in Cancer Therapy Fatigue

> **NCT01113905** · — · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 18 (actual)

## Conditions studied

- Breast Cancer
- Fatigue

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01113905
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2013-07
- **Final completion:** 2014-08
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Insufficient recruitment was obtained
- **Last updated:** 2014-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01113905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01113905, "Role of Beta-Endorphin in Cancer Therapy Fatigue". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01113905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*